MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such ...

Autism spectrum disorder (ASD) is widely known for its core features, which include difficulties in social communication and ...

A systematic review and meta-analysis of over 140 studies sheds light on which drug classes, including NMDA-receptor antagonists and VGSC blockers, can reduce secondary hyperalgesia.

SaveHealth reports on advancements in dementia medications, highlighting new treatments that modify disease progression and ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 12:40 PM EDT ...

More than 4 out of 10 dementia patients with Alzheimer's disease stop taking therapeutic drugs within a year of starting ...

Gary Iacobucci, a general psychiatry resident and research assistant professor in biochemistry in the Jacobs School, has been selected to receive the National Institute on Mental Health's prestigious ...

Jupiter Hospital recently managed a rare and challenging case of NMDA receptor positive autoimmune encephalitis in a ...

Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile ...

Over the last three decades, the evidence on how to best treat the cognitive and non-cognitive symptoms of patients with ...